ND
Insider
Nathan J Dowden
President & COONathan J Dowden (President & COO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Entrada Therapeutics, Inc. (TRDA). The largest single filing was $230K of TRDA (15,000 sh × $15.33, as filed), executed May 4.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$385K
shares × price, as filed
Last traded
May 4
Filed May 4
Median ADV $2.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $385K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
TRDARecent filings
TRDASALE
Entrada Therapeutics, Inc.
View filing →
$230K15,000 sh × $15.33
Exec May 4
Filed May 4 · 5:30 PM ET TRDASALE Entrada Therapeutics, Inc. View filing → $155K
11,894 sh × $13.05
Exec Mar 10
Filed Mar 11 · 5:30 PM ET